Proton Health
Techstars '24London, GB · 3 employees on LinkedIn · 1 known investors
Find your way into Proton Health
Proton Health operates Symphony, an AI-powered platform that helps people with chronic skin conditions (acne, eczema, psoriasis, topical steroid withdrawal) identify triggers by analyzing data on symptoms, lifestyle, diet, stress, and products. The platform provides personalized recommendations and connects users with dermatology specialists for consultations and testing.
Also known as Symphony
Founders & leadership
Investors · 1
How we know: the Techstars portfolio · open dataset · Top 3000 Accelerator Startups (no YC) 2026-08 · Not right? Tell us
Company profile
researched Sep 2026Proton Health is a London-based healthcare technology company that develops Symphony, an AI-driven dermatology platform for people living with chronic skin conditions including eczema, acne, rosacea, psoriasis, hyperpigmentation, redness and dryness. The product is built around identifying the causes of flares rather than treating symptoms alone: users complete a "360° scan" capturing photos, symptoms, lifestyle, mental health, diet and product use, and Symphony compares that profile against large volumes of dermatology data to surface candidate triggers such as stress, sleep, weather, skincare products and foods.
The platform then produces a personalized plan spanning skincare, diet, lifestyle and mental wellbeing. Additional modules include analysis of skincare product ingredients against a user's profile, more than 50 mental wellbeing sessions addressing issues such as social anxiety, the itch-scratch cycle and self-esteem, and condition-specific educational lessons. For users seeking deeper clinical investigation, Symphony offers dermatology consultations, gut and skin microbiome testing and full lab panels.
A private-market data profile classifies Proton Health under telemedicine, patient engagement and medical AI, and describes Symphony as supporting both patients and dermatologists.
Business model
Proton Health operates a subscription-based digital health service delivered directly to consumers through the Symphony app, offering a free initial assessment followed by personalized plans, educational lessons and mental wellbeing content. Paid clinical add-ons include dermatology consultations, gut and skin microbiome testing and laboratory panels. A third-party private-market profile characterizes the company as B2B with subscription SaaS and freemium customer profiles, and records the addition of a pharmaceutical company as a customer.
Freemium and subscription access to the Symphony app, with paid clinical services such as dermatology consultations, microbiome testing and lab panels available as upgrades.
Traction
The company reports more than 4,500 users of Symphony and a 4.9 out of 5 average rating, and states that 92% of members identify at least one new trigger within seven days. Outcome claims on quality of life, skin concern and mental wellbeing improvement are attributed to an internal Proton Health outcomes dataset covering 2021-24, measured as average change at 90 days. A private-market data provider reported a 76% month-over-month increase in monthly visitors in August 2026.
Latest developments
A private-market data provider recorded a 76% month-over-month increase in monthly visitors in August 2026, and noted UCB Group, a pharmaceuticals company, as a customer added in June 2025.
▸Full profile — market position, technology, go-to-market, geography, history
Market position
A small, early-stage digital dermatology company with two recorded employees; a private-market data provider lists Skinive, Miiskin and Teladoc Health as the most similar companies by industry and business-model comparison.
The platform's stated focus is root-cause and trigger identification across a wide set of lifestyle, environmental and product variables, rather than symptom tracking or teledermatology consultation alone, combined with mental wellbeing content addressing the psychological burden of skin disease and optional clinical testing pathways.
Technology
Symphony analyzes user-submitted photographs, symptom logs, lifestyle, diet, mental health and product-use data against large dermatology datasets to detect patterns and infer individual flare triggers, and applies ingredient-level analysis of thousands of skincare products against each user's profile. It is characterized externally as an application-layer AI product.
Go-to-market
Direct-to-consumer acquisition via a free online assessment that funnels users into the Symphony app, supported by user reviews and app ratings; a private-market profile also indicates at least one pharmaceutical company relationship.
Consumers living with chronic skin conditions such as eczema, acne, rosacea and psoriasis, particularly those who have not found resolution through conventional dermatology care; the platform is also positioned as providing clinical support for dermatologists.
Geography
Headquartered in London, United Kingdom, with a consumer app distributed online.
History
The company was founded in 2020 and is headquartered in London. Its outcomes dataset referenced on the company site spans 2021-24, indicating the platform has been in use with members over that period. Funding history recorded by a private-market data provider includes grants dated November 2022 and May 2023 and an accelerator round in September 2024, with Innovate UK, the National Institute for Health and Care Research, Techstars, UNT Health Science Center and Goff Capital listed among investors.
Compiled by commissioned research from 6 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Competitors · 1
by search overlapCompanies competing with Proton Health for the same Google search keywords, organic and paid, via search-intersection analysis.
Timeline · 4
launches, deals, and filingsA market signal records the addition of UCB Group, a pharmaceuticals company, as a customer.
Caplight records an accelerator round dated September 2024, with Techstars listed among investors; total funding raised to date listed as $236,000.
A grant dated May 2023 is listed in Proton Health's funding history, with Innovate UK and the National Institute for Health and Care Research listed among investors.
A grant dated November 2022 is listed in Proton Health's funding history.
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
Legal entities · 1
corporate structureCompanies House · registry record
View on Companies House ↗- Registered name
- PROTON HEALTH LTD
- Company number
- 12578120
- Status
- Active
- Company type
- Private limited company
- Incorporated
- 29 Apr 2020
- Registered office
- 7 Bell Yard, London, WC2A 2JR
- Nature of business (SIC)
- 62012 — Business and domestic software development
- Previous names
- ECZEMADOC LTD (2020–2022)
- Accounts
- last made up to 30 Apr 2025 · next due 31 Jan 2027
- Confirmation statement
- last made up to 28 Apr 2026 · next due 12 May 2027
Current officers · 2
- Haroon Ahmad — director, appointed 29 Apr 2020
- Niall Haydar Jawad — director, appointed 29 Apr 2020
Source: Companies House public register · retrieved 24 Jul 2026. Contains public sector information licensed under the Open Government Licence v3.0.
▸Research sources · 6
primary sources listed
- Proton Healthproton-health.com · web
6 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Proton Health do?
- London-based digital health company behind Symphony, an AI dermatology app that identifies triggers behind chronic skin conditions.
- Who founded Proton Health?
- Proton Health was founded by Dr. Niall Jawad.
- Who are Proton Health's investors?
- Proton Health's investors include Techstars.
- Where is Proton Health headquartered?
- Proton Health is headquartered in London, GB.

